 Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- NIDDM
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
- Diabetes Mellitus, Noninsulin Dependent
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1984 | 0 | 2 | 2 | | 1988 | 5 | 0 | 5 | | 1989 | 3 | 0 | 3 | | 1990 | 3 | 1 | 4 | | 1991 | 3 | 0 | 3 | | 1992 | 11 | 1 | 12 | | 1993 | 5 | 1 | 6 | | 1994 | 9 | 2 | 11 | | 1995 | 19 | 3 | 22 | | 1996 | 18 | 1 | 19 | | 1997 | 16 | 3 | 19 | | 1998 | 6 | 3 | 9 | | 1999 | 5 | 1 | 6 | | 2000 | 25 | 4 | 29 | | 2001 | 11 | 3 | 14 | | 2002 | 15 | 5 | 20 | | 2003 | 7 | 5 | 12 | | 2004 | 18 | 5 | 23 | | 2005 | 24 | 4 | 28 | | 2006 | 21 | 4 | 25 | | 2007 | 19 | 6 | 25 | | 2008 | 21 | 6 | 27 | | 2009 | 19 | 6 | 25 | | 2010 | 20 | 5 | 25 | | 2011 | 29 | 7 | 36 | | 2012 | 24 | 4 | 28 | | 2013 | 29 | 3 | 32 | | 2014 | 41 | 6 | 47 | | 2015 | 29 | 4 | 33 | | 2016 | 37 | 4 | 41 | | 2017 | 22 | 6 | 28 | | 2018 | 35 | 8 | 43 | | 2019 | 34 | 3 | 37 | | 2020 | 26 | 6 | 32 | | 2021 | 15 | 2 | 17 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Wang J, Sato T, Sakuraba A. Worldwide association of lifestyle-related factors and COVID-19 mortality. Ann Med. 2021 12; 53(1):1528-1533.
-
Beltrán S, Arenas DJ, López-Hinojosa IJ, Tung EL, Cronholm PF. Associations of Race, Insurance, and Zip Code-Level Income with Nonadherence Diagnoses in Primary and Specialty Diabetes Care. J Am Board Fam Med. 2021 Sep-Oct; 34(5):891-897.
-
Kahn SE, Edelstein SL, Arslanian SA, Barengolts E, Caprio S, Ehrmann DA, Hannon TS, Marcovina S, Mather KJ, Nadeau KJ, Utzschneider KM, Xiang AH, Buchanan TA. Effect of Medical and Surgical Interventions on a-Cell Function in Dysglycemic Youth and Adults in the RISE Study. Diabetes Care. 2021 09; 44(9):1948-1960.
-
Kahn SE, Mather KJ, Arslanian SA, Barengolts E, Buchanan TA, Caprio S, Ehrmann DA, Hannon TS, Marcovina S, Nadeau KJ, Utzschneider KM, Xiang AH, Edelstein SL. Hyperglucagonemia Does Not Explain the ß-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study. Diabetes Care. 2021 09; 44(9):1961-1969.
-
Peek ME, Thomas CC. Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes. JAMA. 2021 06 08; 325(22):2255-2257.
-
Santos EE, Korah J, Subramanian S, Murugappan V, Huang ES, Laiteerapong N, Cinar A. Analyzing Medical Guideline Dissemination Behaviors Using Culturally Infused Agent Based Modeling Framework. IEEE J Biomed Health Inform. 2021 06; 25(6):2137-2149.
-
Xiang AH, Martinez MP, Trigo E, Utzschneider KM, Cree-Green M, Arslanian SA, Ehrmann DA, Caprio S, Mohamed PHIH, Hwang DH, Katkhouda N, Nayak KS, Buchanan TA. Liver Fat Reduction After Gastric Banding and Associations with Changes in Insulin Sensitivity and ß-Cell Function. Obesity (Silver Spring). 2021 07; 29(7):1155-1163.
-
Kohn OF. In CKD, the effect of dapagliflozin on kidney outcomes did not vary by T2DM status or CKD cause. Ann Intern Med. 2021 05; 174(5):JC53.
-
Kohn OF. SGLT2 inhibitors reduce all-cause mortality. Ann Intern Med. 2021 05; 174(5):JC52.
-
Arnott C, Li JW, Cannon CP, de Zeeuw D, Neuen BL, Heerspink HJL, Charytan DM, Agarwal A, Huffman MD, Figtree GA, Bakris G, Chang TI, Feng K, Rosenthal N, Zinman B, Jardine MJ, Perkovic V, Neal B, Mahaffey KW. The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial. Diabetes Obes Metab. 2021 07; 23(7):1652-1659.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|